Ivermectin inhibits molting of Wuchereria bancrofti third stage larvae in vitro.
The effect of ivermectin or diethylcarbamazine (DEC) on Wuchereria bancrofti molting from the third to the fourth larval stage (L3 to L4) was evaluated in vitro. L3 larvae were harvested from laboratory-reared Aedes togoi 2 wk after feeding upon a microfilaremic human volunteer. The larvae were kept in an artificial medium (Franke's NI medium) with 10% human serum under an atmosphere of 5% CO2 for 20 days. Experimental tubes also contained ivermectin (0.1-1,000 ng/ml) or DEC (0.1-10,000 ng/ml). An estimated concentration of 50 ng/ml ivermectin inhibited molting in 50% of the larvae expected to molt. For DEC, this value was roughly 1,000 ng/ml. In this in vitro culture system, ivermectin inhibited the L3 to L4 molt of W. bancrofti and was roughly 20-fold more potent in this activity than DEC.
Baird
J K
JK
U.S. Naval Medical Research Unit #2, Jakarta Detachment, APO San Francisco 96356-5000.
Riberu
W
W
Masbar
S
S
Purnomo
D000818:Animals; D003470:Culture Media; D004049:Diethylcarbamazine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007559:Ivermectin / Q000494:pharmacology*; D007814:Larva / Q000187:drug effects / Q000502:physiology; D014958:Wuchereria bancrofti / Q000187:drug effects* / Q000502:physiology
D003470:Culture Media; D007559:Ivermectin; D004049:Diethylcarbamazine